SCHEMBL18620549

SCHEMBL18620549

CCc1cc(N)nc(N)c1/N=N/c1ccc(Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 12/20 0.51
▸ RECQL P46063 1/20 0.51
▸ KMT2A Q03164 11/20 0.46
▸ MEN1 O00255 10/20 0.46
▸ MAPK1 P28482 5/20 0.46
▸ GAA P10253 2/20 0.46
▸ SMN1; SMN2 Q16637 5/20 0.45
▸ TDP1 Q9NUW8 6/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ ATM Q13315 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ ALOX5 P09917 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ LMNA P02545 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ CA12 O43570 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20672109 0.81 MAPT (0.44) MAPTRECQLKMT2AMEN1MAPK1
SCHEMBL17595330 0.80 MAPT (0.54) MAPTRECQLKMT2AMEN1MAPK1
SCHEMBL17595329 0.80 MAPT (0.54) MAPTRECQLKMT2AMEN1MAPK1
SCHEMBL17595117 0.78 MAPT (0.51) MAPTRECQLKMT2AMEN1MAPK1
SCHEMBL17595119 0.78 MAPT (0.51) MAPTRECQLKMT2AMEN1MAPK1
SCHEMBL19295489 0.78 MAPT (0.48) MAPTRECQLKMT2AMEN1MAPK1
SCHEMBL18586819 0.77 MPO (0.50) MAPTRECQLKMT2AMEN1MAPK1
SCHEMBL18586823 0.77 MPO (0.50) MAPTRECQLKMT2AMEN1MAPK1
SCHEMBL18616415 0.76 MAPT (0.41) MAPTRECQLKMT2AMEN1MAPK1
SCHEMBL18586035 0.76 MAPT (0.45) MAPTRECQLKMT2ATDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017040451-A1 TRIAZOLOPYRIDINE INHIBITORS OF MYELOPEROXIDASE BRISTOL-MYERS SQUIBB COMPANY (US) 2017-03-09 — — WO disclosed
Send feedback